Acamprosate - CISMeF

Preferred Label : Acamprosate;

MeSH definition : Structural analog of taurine that is used for the prevention of relapse in individuals with ALCOHOLISM.;

MeSH synonym : Acamprostate; N-Acetylhomotaurine; N Acetylhomotaurine;

MeSH Hyperonym : Calcium Acetylhomotaurine; Acetylhomotaurine, Calcium; Calcium Acetylhomotaurinate; Acetylhomotaurinate, Calcium; N-Acetylhomotaurine, Calcium (2:1) Salt; Calcium Acetyl Homotaurinate; Acetyl Homotaurinate, Calcium;

MeSH hyponym : N Acetylhomotaurine, Monolithium Salt; N Acetylhomotaurine, Monosodium Salt; Sodium Acetylhomotaurine; Acetylhomotaurine, Sodium; N Acetylhomotaurine, Monopotassium Salt;

MeSH CAS label : 1-Propanesulfonic acid, 3-(acetylamino)-;

MeSH Related Number : 59375N1D0U; 77337-70-3 (mono-Na salt); 77337-71-4 (mono-K salt); 77337-72-5 (mono-Li salt); 77337-74-7 (Mg[2:1] salt); 77337-75-8 (Zn[2:1] salt); 77337-76-9 (Acamprosate);

UNII : N4K14YGM3J;

Details

Origin ID

D000077443;

UMLS CUI

C0284941;

ATC code(s)
- acamprosate [ATC Code]
ATC code(s)
- acamprosate [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- calcium(2+) 3-(acetylamino)propanesulphonate [Substance BNPC]
- lithium 3-(acetylamino)propanesulphonate [Substance BNPC]
- magnesium(2+) 3-(acetylamino)propanesulphonate [Substance BNPC]
- potassium 3-(acetylamino)propanesulphonate [Substance BNPC]
- sodium 3-(acetylamino)propanesulphonate [Substance BNPC]
CISMeF manual mappings
- 3-(acetylamino)propanesulphonic acid [Substance BNPC]
Pharmacological action(s)
- alcohol deterrents [MeSH Descriptor]
Record concept(s)
- Campral [MeSH concept]
- N-acetylhomotaurine, magnesium (2:1) salt [MeSH concept]
- N-acetylhomotaurine, monolithium salt [MeSH concept]
- N-acetylhomotaurine, monopotassium salt [MeSH concept]
- N-acetylhomotaurine, monosodium salt [MeSH concept]
- N-acetylhomotaurine, zinc (2:1) salt [MeSH concept]
- Regtect [MeSH concept]
- acamprosate [MeSH concept]
- acamprosate calcium [MeSH concept]
- aotal [MeSH concept]
- campral EC [MeSH concept]
- zulex [MeSH concept]
Related MeSH Supplementary Concept(s)
- acamprosate, ribavirin drug combination [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Validated automatic mappings to BTNT
- Acamprosate Calcium [NCIt concept]
- Acamprosate calcium [SMS substance]
- Acamprosate calcium (substance) [SNOMED CT concept]
- acamprosate [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients